Needle-Free Injections Market Is Growing At A CAGR Of 14.15% During The Forecast Period From 2021 To 2026 And Will Reach USD
Bloomberg: DelveInsight launched
a new report on ” Needle-Free Injections Market & Competitive Landscape ,”
providing in-depth market understanding for Needle-Free Injections, which will
further benefit the competitors or stakeholders operating in the Needle-Free
Injections arena. Recent Developmental Activities in Needle-Free
Injections Market * In August 2021, PharmaJet and their partner Zydus
Cadila announced the emergency Use Authorization (EUA) from the Drug Controller
General of India (DCGI) for ZyCoV-D, the world’s first Plasmid DNA Vaccine for
COVID-19.
Comments
Post a Comment